Anti-tumour necrosis factor alpha therapy modulates ghrelin in patients with severe rheumatoid arthritis.
M A
MA
Gonzalez-Gay
M T
MT
Garcia-Unzueta
A
A
Berja
T R
TR
Vazquez-Rodriguez
C
C
Gonzalez-Juanatey
J M
JM
de Matias
J
J
Martin
P H
PH
Dessein
J
J
Llorca
D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D015331:Cohort Studies; D005260:Female; D054439:Ghrelin / Q000097:blood*; D006801:Humans; D000069285:Infliximab; D008297:Male; D008875:Middle Aged; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D054439:Ghrelin; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab